Cost neutrality of BLC versus WLC in a real-world setting demonstrated by new OPTUM study in the U.S.

Contributed by: PR Newswire

Tags

PHOTOCURE-New-Study

More Like This

The impact of avoiding recurrence: New BRAVO Study abstract at SUO 2025 demonstrates Cost Neutrality in Blue Light versus White Light Cystoscopy comparison

AUA 2026: new studies demonstrated Blue Light Cystoscopy benefits in high-risk NMIBC management and cost comparison study

New Health Economic analysis in France concludes there is insignificant cost difference between White Light and Blue Light Cystoscopy use when applying ccAFU guidelines

Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024

New health economic methodology published: comparing cost-effectiveness of BLC versus NBI imaging technology in bladder cancer

New budget impact model study in 4 European countries concludes that BLC use offers a clinically meaningful and economically rational approach to NMIBC management

New BRAVO Study Publication Reinforces Clinical Benefits of BLC in Reducing Risk of Bladder Cancer Recurrence

New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy